AD
Insider selling
Aaron Deykin sold $5K of UPB stock
Aaron Deykin, Chief Medical Officer of Upstream Bio, Inc. (UPB), sold 895 shares of UPB stock worth $5K, per an SEC Form 4 filed Jun 17, 2026.
It was an open-market sale.
The trade happened on Jun 16, 2026, 1 day before it was made public.
UPB has moved -42.4% since the trade date, from $5.92 to $3.41 (Oct 30, 2026 close).
- Traded
- Jun 16, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 1 day
- Price since
- -42.4%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More UPB insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.